|
Type of Company:
Type:
|
Company
|
Ownership: |
Publicly Traded (NVCN, Toronto Stock Exchange) |
Revenue: |
$5.40 Million CAD |
Year Founded: |
2000 |
Sector: |
Biotech/Life Sciences
Biotech/Life Sciences
|
Region: |
Lower Mainland / South Coast
Lower Mainland
|
Tags: |
medical device, cardiovascular, Tiara, Neovasc Reducer, pericardial tissue processing
|
Profile Views: |
7,523 Company Profile Views |
|
|
Neovasc Inc. is a specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular marketplace.
Our products include the Tiara™ technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer™ for the treatment of refractory angina.
A Canadian Biotech company, headquartered in Vancouver, B.C. Canada, we are a publicly traded company, listed on NASDAQ: (NVCN) and the Toronto Stock Exchange TSX: (NVCV).
|
|
|
Date |
Type |
Amount |
Investors |
Jan 22, 2023 |
Unattributed |
$147 Million USD |
|
Date |
Type |
Amount |
Investors |
Jan 22, 2023 |
Unattributed |
$147M USD |
|
|
|
|
Jan 23, 2023
|
Vancouver-based Neovasc to Be Acquired by Shockwave Medical for Up to $197 Million (US $147M)
|
Dec 13, 2021
|
Neovasc Reducer System Receives National Reimbursement in France
|
Jan 7, 2020
|
Neovasc Named Finalist in Questex’s Fierce Innovation Awards– LifeSciences Edition 2019
|
May 23, 2019
|
Richmond, BC-based Medical Device Company Neovasc Closes US $11.5 Million Financing of Convertible Debt and Common Shares
|
Apr 5, 2019
|
Neovasc Wins German Court Appeal; Announces German Court's Decision to Dismiss CardiAQ's Claim to Co-inventorship
|
Apr 2, 2019
|
Neovasc Announces Closing of $5 Million Public Offering of Common Shares
|
Feb 4, 2019
|
Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK
|
Feb 1, 2019
|
Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences
|
Jan 3, 2019
|
Neovasc Receives ISO 13485: 2016 Certification
|
Dec 11, 2018
|
Neovasc Announces Third Quarter 2018 Financial Results
|
|
1 - 10 of 87 results
|
|
 |
|
|
|
Share This Company Profile |
|
Disclaimer: Company Profiles in the Tech Directory on T-Net are created, edited and maintained primarily by employees within individual companies, and are subject to continual change without notice and possible errors and/or omissions. Information within the pages of this Tech Directory is of a general nature intended only for informational purposes, and such information should not be relied upon. T-Net does not warrant or guarantee the quality, accuracy or completeness of such information and expressly disclaims liability for any loss, inconvenience or damages (including special, indirect or consequential damages) caused as a result of any errors in, or omissions from, such information. If you see an error, please let us know. Copyright T-Net. All rights reserved.
|
|